Stay updated on Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:39:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.1 on the ClinicalTrials.gov page for NCT03333746. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:17:52.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding status notice that warned about potential updates and operational delays. The page no longer displays this funding-related banner.
    Difference
    0.4%
    Check dated 2025-11-17T06:20:41.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study record content appears unchanged apart from formatting/UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:58:12.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T09:14:04.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    - Removed a specific resource entry (Genetic and Rare Diseases Information Center resources: Plasma cell myeloma) and - updated the revision version to v3.1.0, replacing the previous v3.0.2.
    Difference
    0.5%
    Check dated 2025-09-28T03:05:42.000Z thumbnail image

Stay in the know with updates to Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.